Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A new study ...

Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...

This story was originally published in Group Therapy, a weekly newsletter answering questions sent by readers about what’s been weighing on their hearts and minds. Sign up here to get it in your inbox ...

Human Geneticist Dr. Neville Sanjana answers the internet’s burning questions about genetics and DNA. How are our genes related to our DNA? Does our DNA change during our lifetime? How do services ...

About a year ago, the US Food and Drug Administration (FDA) granted premarket approval to AvertD (SOLVD Health), the first genetic test to assess an individual’s risk of developing opioid use disorder ...

Genetic counselors, who help people navigate tests, have concerns about how those who have taken the test will interpret their results.

People trying to lose weight often count calories, carbs, steps and reps and watch the scales. Soon, they may have another number to consider: a genetic score indicating how many calories a person ...

Please provide your email address to receive an email when new articles are posted on . A genetic biomarker test was able to predict patients’ semaglutide treatment response after bariatric surgery.

A world-first study has shown that it is possible to determine who is likely to get depression in late-life based on a "genetic score." The longitudinal study of more than 12,000 people over 70 paves ...